Showing results (211-220 of 513) with videos related to
Sort By:
Pageof 52
Infection and Immunity|July 11, 2012
Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops)John J Yeager, Paul Facemire, Paul A Dabisch, et al.Biophysical Journal|May 13, 2017
Microvessel Chaste: An Open Library for Spatial Modeling of Vascularized TissuesJames A Grogan, Anthony J Connor, Bostjan Markelc, et al.Vaccine|May 17, 2011
Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plagueE D Williamson, P J Packer, E L Waters, et al.Oncoimmunology|September 19, 2017
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanomaNicolas Jacquelot, Jonathan M Pitt, David P Enot, et al.Traffic Injury Prevention|April 16, 2019
Adaptation of a Canadian culpability scoring tool to Alberta police traffic collision report dataTona M Pitt, Janet Aucoin, Alberto Nettel-Aguirre, et al.Clinical Immunology (Orlando, Fla.)|July 17, 2003
Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunityJames W Boles, M Louise M Pitt, Ross D LeClaire, et al.Vaccine|October 26, 2005
Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infectionTaff Jones, Jeffrey J Adamovicz, Sonya L Cyr, et al.The Journal of Pediatrics|January 1, 1985
Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and seasonE O Reiter, S M Brugman, J W Pike, et al.Traffic Injury Prevention|April 10, 2025
Risky driving behaviors at school drop-off across Canadian municipalities: Findings from the Child Active Transportation Safety and the Environment (CHASE) studyTona M Pitt, Alison Macpherson, Liraz Fridman, et al.Vaccine|January 19, 2006
Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccineS F Little, B E Ivins, W M Webster, et al.Pageof 52